THIS ANNOUNCEMENT CONTAINS INSIDE
INFORMATION
Spectris - Third quarter 2024 trading update
31 October 2024 - Spectris plc (SXS:
LSE), the expert in providing insight through precision
measurement, provides a trading update for the three-month period
ended 30 September 2024 ('the period').
Accelerating action to drive
profitability and to capitalise on market recovery
· While
our third quarter performance indicates markets have stabilised,
the recovery anticipated at the time of our half year results is
taking longer to materialise
· Third
quarter orders and sales consistent with the first half:
o Like-for-like (LFL) orders 6% lower in the quarter (6% lower
on a year-to-date basis)
o LFL
sales 10% lower in the quarter (10% lower on a year-to-date
basis)
· ERP
back on track - progressive recovery of sales rephased from H1
expected to be completed by year-end
· Increasing and accelerating actions to reduce cost base and
drive profitability in addition to synergy realisation and benefits
from ERP implementation
· Acquisitions represent a meaningful growth driver in 2025,
with integration planning for Micromeritics and SciAps progressing
well and acquisition of Piezocryst expected to complete around the
end of the year
· Guidance and full year outlook:
o We
now expect to deliver adjusted operating profit for the Group for
the full year, including the contribution from the two completed
acquisitions, of around £200 million
o Restructuring programme to deliver around £50 million run rate
benefits, with associated costs of between £15 million and £20
million in 2024 with further restructuring and integration-related
costs of £20 million to £25 million in 2025
Andrew Heath, Chief Executive,
said:
"During the third quarter the headwinds that we described at
the half year - most notably continued softness in China,
pharma and academia - have persisted and, from what we can see
today, are likely to continue into the early part of
2025. Against this backdrop, we have increased and accelerated
cost reduction activities to improve the Group's productivity and
drive profitability. This decisive action on cost, and a
strong focus on executing our strategy, means the Group is well
placed to benefit as our end markets recover.
Over recent years we have significantly improved the quality
of the Spectris portfolio, which today comprises market leading
premium precision measurement businesses, aligned behind a common
purpose, and capable of delivering through-cycle growth and margin
expansion. The high-quality acquisitions we have made this year
have strengthened our platform significantly, and the enhancements
to our customer propositions, and confidence in synergy delivery is
structurally increasing our ability to deliver against our
medium-term financial targets."
Sales by geography and division -
LFL growth Q3 2024 vs Q3 2023
|
By division
|
|
By region
|
Spectris
Scientific
|
-8%
|
North
America
|
-9%
|
Spectris
Dynamics
|
-13%
|
Europe
|
-12%
|
|
|
Asia
|
-10%
|
|
|
Rest of the
World
|
0%
|
Total
sales
|
-10%
|
|
-10%
|
Group reported sales decreased by
13% (£46.4 million) to £302.7 million (Q3 2023: £349.1
million). LFL sales were down 10%, with lower sales across
all regions, with the impact of foreign currency exchange and
disposals net of acquisitions reducing sales by 2% and 1%
respectively.
·
In Spectris
Scientific, order intake in the quarter was slightly up on a
LFL basis, with good demand in both semiconductor and materials
partially offset by continued softness in academia and
batteries. Demand in pharma/life sciences was broadly in line
with the comparative period. Sales in the period were 8%
lower on a LFL basis largely driven by semiconductor and materials
against strong comparators.
Year-to-date, broadly flat demand in
materials and semiconductor has been more than offset by the
softness in academia; on a regional basis, flat demand in North
America was outweighed by slightly lower demand in Europe and
softness in Asia, notably China.
· In Spectris Dynamics,
orders were down on a LFL basis in the period, largely driven by
weaker order intake in automotive reflecting the broader, recent
pull back in demand across the sector. LFL sales in the
quarter were 13% lower with good growth in A&D more than offset
by lower sales in machine manufacturing and automotive. LFL
sales were lower in all regions except Asia, against a strong
comparator.
Year-to-date, continuing good demand
in A&D and flat demand in auto and machine manufacturing has
been more than offset by a number of other end markets, including
academia; regionally, overall softer demand in the division has
been driven by North America.
Quarterly Group sales
|
2023
|
2024
|
|
Q1
|
Q2
|
Q3
|
Q4
|
Q1
|
Q2
|
Q3
|
£ million
|
354.3
|
348.2
|
349.1
|
397.6
|
309.4
|
280.3
|
302.7
|
LFL growth
|
24%
|
15%
|
11%
|
-3%
|
-8%
|
-12%
|
-10%
|
Strategy update
In August, we completed the acquisitions of Micromeritics and SciAps in
Spectris Scientific for combined headline consideration of £642
million and integration planning is progressing well. In
September, we announced the acquisition of Piezocryst in Spectris
Dynamics, a leading provider of
piezoelectric sensors, for €133.5 million (£112 million) which we
expect to complete around the end of the year.
We are pleased with the performance
of our new ERP system in Malvern Panalytical, with the revenue
rephased from the first half being progressively recovered and
expected to be completed by the year-end. In September, we
completed the first phase of the implementation of the new system
in Spectris Dynamics applying the learnings from the initial
implementation.
Restructuring programme
Our actions to reduce the cost base
comprise three core elements: (1) general cost and efficiency
measures in addition to those announced at the half year; (2) the
realisation of cost synergies associated with the acquisitions
announced in 2024; and (3) crystallisation of the benefits
associated with the implementation of our new ERP system. The
programme is expected to deliver approximately £50 million of full
run rate benefits, of which £30 million is expected in 2025 with
the remaining £20 million in 2026.
Capital allocation and balance
sheet
Shortly after the period end, we
completed the second £50 million tranche of our £150 million share
buyback programme. We expect to start the final tranche in
the new year. Net debt was £393 million at the end of
September 2024. In the event the Piezocryst acquisition completes
before the end of the year, Group leverage, as measured by net
debt:EBITDA, is expected to be around the upper end of our target
range of 1x to 2x.
Conference call
A conference call for analysts and
investors will be hosted by Andrew Heath, Chief Executive, and
Angela Noon, Chief Financial Officer, at 8.00am today to discuss
this statement. To access the call, please dial +44 (0) 20
3936 2999, toll free +44 (0) 800 358 1035 - Participant code:
437574. Or for replay, please dial +44 (0) 20 3936 3001 -
Participant code: 940415.
On 10 December, Spectris will be
holding a virtual presentation for investors and analysts on our
Servomex business.
Spectris will publish its full-year
results for 2024 on Friday, 28 February 2025.
END
For and on behalf of Spectris
plc
LEI Number:
213800Z4CO2CZO3M3T10
Contacts:
Spectris plc
Mathew Wootton
Investor Relations
Director
+44 7500 078 880
Teneo
Martin Robinson/Giles
Kernick
+44 20 7353 4200
This Announcement contains inside
information for the purposes of article 7 of the Market Abuse
Regulation (EU) 596/2014 which is part of UK law by
virtue of the European Union (withdrawal) Act 2018. The person
responsible for arranging for the release of this Announcement on
behalf of the Company is Rebecca Dunn, Company
Secretary.
About Spectris
Spectris combines precision with
purpose, delivering progress for a more sustainable world. We
provide critical insights to our customers through premium
precision measurement solutions combined with technical expertise
and deep domain knowledge. Precision is at the heart of what we do
- our leading, high-tech instruments and software equip our
customers to solve some of their greatest challenges to make the
world cleaner, healthier and more productive. We are focused on two
key divisions - Spectris Scientific and Spectris Dynamics, which
are placed in technology-driven end markets, with strong
fundamentals and attractive growth trajectories. We have
leading market positions in premium segments and employ 7,600
people located in more than 30 countries, all united behind our
purpose to deliver value beyond measure for all our stakeholders.
For more information, visit www.spectris.com.